BMRN vs MSFT: Which Stock is Better?
Side-by-side comparison of Biomarin Pharmaceutical Inc and Microsoft Corporation in 2026
BMRN
Biomarin Pharmaceutical Inc
$65.75
MSFT
Microsoft Corporation
$510.89
Key Metrics Comparison
| Metric | BMRN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $10.63B | $3.71T | MSFT |
| P/E Ratio | 21.45 | 33.89 | BMRN |
| EPS (TTM) | $2.69 | $14.08 | MSFT |
| Revenue Growth | 4.1% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze BMRN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BMRN or MSFT a better investment?
Comparing BMRN and MSFT: Biomarin Pharmaceutical Inc has a market cap of $10.63B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BMRN and MSFT?
BMRN (Biomarin Pharmaceutical Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BMRN or MSFT?
Based on P/E ratios, BMRN trades at a lower multiple (21.5x vs 33.9x).
Which is growing faster: BMRN or MSFT?
MSFT has higher revenue growth at 18.4% vs 4.1% for BMRN.
Which company is more profitable: BMRN or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for BMRN.
Which is the larger company: BMRN or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $10.63B for BMRN.
Should I buy BMRN or MSFT in 2026?
Both BMRN and MSFT have investment merit. BMRN trades at $65.75 while MSFT trades at $510.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BMRN and MSFT stock?
Key differences: Market Cap ($10.63B vs $3.71T), P/E Ratio (21.5x vs 33.9x), Revenue Growth (4.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy BMRN or MSFT in 2026?
The choice between BMRN and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BMRN and MSFT?
BMRN (Biomarin Pharmaceutical Inc) has a market cap of $10.63B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.